GS

Garima Sharma

Senior Research Analyst Payer Stakeholder Management at Market Access Transformation, a Genesis Research company

Garima Sharma is an experienced professional in the field of global stakeholder management and clinical research. Currently serving as Associate Manager at Genesis Research Group since November 2022, Garima has previously held roles including Senior Research Analyst at Larvol, Lead Associate Operations at WNS Global Services, and Clinical Research Coordinator at Vimhans Nayati Super Speciality Hospital. Garima’s expertise encompasses KOL tracking, pipeline analysis, and clinical trial monitoring across various therapeutic areas, with a solid foundation in GCP and ICH guidelines. Garima's academic qualifications include a B.Sc. from Himachal Pradesh University and an M.Sc. in Biotechnology from Barkatullah University.

Location

Gurgaon, India

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Market Access Transformation, a Genesis Research company

**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers


Employees

51-200

Links